XTX Topco’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.22M Buy
276,108
+238,907
+642% +$2.29M 0.04% 749
2025
Q4
$433K Sell
37,201
-106,435
-74% -$1.04M 0.01% 1733
2025
Q3
$1.44M Buy
143,636
+126,543
+740% +$1.82M 0.07% 354
2025
Q2
$298K Sell
17,093
-32,554
-66% -$470K 0.01% 1438
2025
Q1
$625K Buy
49,647
+17,429
+54% +$210K 0.03% 859
2024
Q4
$340K Buy
32,218
+14,975
+87% +$210K 0.03% 1110
2024
Q3
$250K Buy
+17,243
New +$205K 0.02% 1310
2023
Q4
Sell
-10,117
Closed -$38.2K 2105
2023
Q3
$38.2K Buy
+10,117
New +$66.4K 0.01% 1305
2022
Q3
Sell
-10,001
Closed -$42K 1362
2022
Q2
$42K Sell
10,001
-12,136
-55% -$42.3K 0.02% 760
2022
Q1
$78K Buy
22,137
+3,321
+18% +$14.5K 0.03% 546
2021
Q4
$125K Buy
+18,816
New +$153K 0.07% 434

Other funds holding SPRY